Skip to Main Content

Paper Details

Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates.
American Journal of Cancer Research (discontinued)
12
2022
Her2, PARP, PD-1, PD-L1, SN-38, TNBC, Triple-negative breast cancer, Trop2, Trop2 ADC, Trop2 positive cancer cells, anti-trophoblast cell-surface antigen 2, breast cancer, estrogen, estrogen receptor, patients, progesterone, progesterone receptors, topoisomerase I, triple-negative breast cancer
Author NameAffiliation
Mien-Chie HungGraduate Institute of Biomedical Sciences, China Medical University Taichung
Mien-Chie HungCenter for Molecular Medicine, China Medical University Hospital Taichung 40402
Mien-Chie HungResearch Center for Cancer Biology, China Medical University Taichung 40402
Mien-Chie HungAsia University Taichung 41354
  • 1 - 4

Datasets

Release 1.2